APA (7th ed.) Citation

JC, C., MA, A., AG, D., M, M., IY, L., H, R., . . . SE, W. (2025). Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system. Lupus, 34(8), 832. https://doi.org/10.1177/09612033251345201

Chicago Style (17th ed.) Citation

JC, Chang, et al. "Hypertension, Proteinuria, and RAAS Inhibition Use in Children with Systemic Lupus Erythematosus: Data from a Multi-institutional Pediatric Learning Health System." Lupus 34, no. 8 (2025): 832. https://doi.org/10.1177/09612033251345201.

MLA (9th ed.) Citation

JC, Chang, et al. "Hypertension, Proteinuria, and RAAS Inhibition Use in Children with Systemic Lupus Erythematosus: Data from a Multi-institutional Pediatric Learning Health System." Lupus, vol. 34, no. 8, 2025, p. 832, https://doi.org/10.1177/09612033251345201.